Cost-Effectiveness and Cost-Utility of Beclomethasone/Formoterol versus Fluticasone Propionate/Salmeterol in Patients with Moderate to Severe Asthma

Background: Asthma is a chronic disease characterized by acute symptomatic episodes with variable severity and duration. Pharmacological asthma management aims to achieve and maintain control without side effects, thus improving quality of life and reducing the economic impact. Recently, a clinical...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical drug investigation 2012-04, Vol.32 (4), p.253-265
Hauptverfasser:	Gerzeli, Simone, Rognoni, Carla, Quaglini, Silvana, Cavallo, Maria Caterina, Cremonesi, Giovanni, Papi, Alberto
Format:	Artikel
Sprache:	eng
Schlagworte:	Albuterol - analogs & derivatives Albuterol - economics Albuterol - therapeutic use Androstadienes - economics Androstadienes - therapeutic use Anti-Asthmatic Agents - economics Anti-Asthmatic Agents - therapeutic use Asthma - drug therapy Asthma - economics Beclomethasone - administration & dosage Beclomethasone - economics Beclomethasone - therapeutic use Computer Simulation Cost-Benefit Analysis Drug Combinations Ethanolamines - administration & dosage Ethanolamines - economics Ethanolamines - therapeutic use Fluticasone-Salmeterol Drug Combination Formoterol Fumarate Humans Internal Medicine Italy Markov Chains Medicine Medicine & Public Health Models, Economic Original Research Article Pharmacology/Toxicology Pharmacotherapy Quality-Adjusted Life Years Severity of Illness Index
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!